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ABSTRACT
During virus infection, viral RNAs and mRNAs function
as blueprints for viral protein synthesis and possibly
as pathogen-associated molecular patterns (PAMPs) in
innate immunity. Here, considering recent research
progress in microRNAs (miRNAs) and competitive
endogenous RNAs (ceRNAs), we speculate that viral
RNAs act as sponges and can sequester endogenous
miRNAs within infected cells, thus cross-regulating the
stability and translational efﬁciency of host mRNAs
with shared miRNA response elements. This cross-talk
and these reciprocal interactions between viral RNAs
and host mRNAs are termed “competitive viral and
host RNAs” (cvhRNAs). We further provide recent
experimental evidence for the existence of cvhRNAs
networks in hepatitis B virus (HBV), as well as Her-
pesvirus saimiri (HVS), lytic murine cytomegalovirus
(MCMV) and human cytomegalovirus (HCMV) infec-
tions. In addition, the cvhRNA hypothesis also pre-
dicts possible cross-regulation between host and
other viruses, such as hepatitis C virus (HCV), HIV,
inﬂuenza virus, human papillomaviruses (HPV). Since
the interaction between miRNAs and viral RNAs also
inevitably leads to repression of viral RNA function,
we speculate that virus may evolve either to employ
cvhRNA networks or to avoid miRNA targeting for
optimal ﬁtness within the host. CvhRNA networks may
therefore play a fundamental role in the regulation of
viral replication, infection establishment, and viral
pathogenesis.
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INTRODUCTION
Currently, viral RNAs are regarded as either templates for
translating viral proteins that exert function or as viral path-
ogen-associated molecular patterns (PAMPs) for detection
by host pattern-recognition receptors (PRRs) in innate anti-
viral immunity (Goubau et al., 2013). However, several
recent studies provide intriguing evidence that viral RNAs
and host mRNAs with common microRNA (miRNA) binding
sequences reciprocally affect each other’s levels and activ-
ities by directly competing with the targeting miRNAs. In this
review, we propose a “competitive viral and host RNAs”
(cvhRNAs) hypothesis, including recent studies on miRNAs
and noncoding RNAs (ncRNAs) expressed by both the host
and virus, as well as the logic of this new and potentially
predictable virus-host interaction.
MIRNAS AND COMPETITIVE ENDOGENOUS RNAS
(CERNAS)
MiRNAs
MiRNAs are a class of small noncoding double-stranded
RNA molecules of approximately 22 nt in length, which
regulate (usually inhibit) target gene expression at the post-
transcriptional level. Full-length miRNAs (pri-miRNAs) are
transcripted by RNA polymerase II, which are processed by
Drosha within the nuclear compartment to produce pre-
miRNAs of about 65 nucleotides in length. The pre-miRNA is
then transported into the cytoplasm and further cleaved by
the RNAse III-like endonuclease Dicer to produce their
mature form miRNAs (Newman and Hammond, 2010). Upon
loading into the RNA-induced silencing complex (RISC),
which contains a member of the double-stranded RNA
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binding protein Argonaute family (Ago), the guide strand of
the miRNA duplex recognizes and binds to conserved
complementary target sites in target mRNAs (often in the 3′-
UTR) through canonical base-pairing between the seed
region of approximately 6- to 8- oligonucleotides. MiRNAs
regulate target gene expression either by inducing their
deadenylation and degradation or by leading to translational
inhibition (Miyoshi et al., 2009; Hu et al., 2012). Thus far,
>2500 human miRNAs (hsa-mir) and 1900 mouse miRNAs
(mmu-mir) have been identiﬁed and described at the miR-
Base website (http://www.mirbase.org, released in Nov.
2013).
CeRNAs
Aside from small regulatory ncRNAs, such as miRNAs, the
transcription machinery in mammalian cells also produces
long noncoding RNAs (lncRNAs) which are typically >200–
300 nt in length. Although currently the function of most of
the annotated lncRNAs remains unknown, emerging studies
show that certain lncRNAs are involved in various physio-
logical processes, including cell-cycle regulation, apoptosis,
and the establishment of cell identity (Ulitsky and Bartel,
2013). Functional lncRNAs may act through several mech-
anisms, including co-transcriptional regulation, cis- or trans-
regulation of gene expression by bridging proteins and
chromatin, titration of RNA-binding factors, and pairing with
other RNAs to trigger post-transcriptional regulation (Ulitsky
and Bartel, 2013; Augui et al., 2011). Poliseno et al. (2010)
further uncovered a unique interaction of the PTEN tumor
suppressor gene and its pseudogene (PTENP1), both of
which are subject to the same miRNA-mediated post-tran-
scriptional regulation (Poliseno et al., 2010). Pseudogenes
harbor premature stop codons, deletions/insertions, and
mutations that abrogate their translation into functional pro-
teins. Interestingly, the PTENP1 3′UTR functions as a decoy
for PTEN-targeting microRNAs due to its ability to compete
for miRNA binding and thus exerts a tumor-suppressive role
by modulating the de-repression of cellular levels of PTEN. A
subsequent study shows that a putative PTEN competitive
endogenous RNA (ceRNA), the ZEB2 transcript, which
contains common miRNA recognition elements with PTEN,
modulates PTEN protein levels in a protein coding-inde-
pendent manner (Karreth et al., 2011). These studies indi-
cate a new means of regulatory interaction between mRNAs
(including both protein-coding and non-coding mRNAs) that
have common microRNA recognition elements.
Further, more recent studies provide compelling evidence
that the crosstalk between ceRNAs through competition for
their shared miRNAs is involved in signaling pathways and
networks in human diseases, such as autoimmune dis-
eases, diabetes and cancer (Ling et al., 2013a, b; Fang
et al., 2013; Noorbakhsh et al., 2013; Karreth and Pandolﬁ,
2013). Together, these newly deﬁned mRNA-mRNA inter-
actions have integral roles in the regulation of gene
expression in various physiological and pathological pro-
cesses and deepen our understanding of a novel aspect of
RNA function.
THE CVHRNAS HYPOTHESIS
Somewhat differently from the mechanism mentioned above
and unlike cellular endogenous RNAs, viral RNAs and
mRNAs are exogenous in virus-infected cells. In addition,
viral RNAs are mostly studied as passive targets for host
miRNAs (Fig. 1A). Indeed, a large number of impressive
experiments have been performed, primarily on binding site
validation and functional analyses, which support the notion
that the interaction between miRNAs and viral RNAs as their
targets is essential to the regulation of viral RNA stability,
expression, and translation, as well as viral replication and
infection (Jopling et al., 2005; Shimakami et al., 2012; Song
et al., 2010; Klase et al., 2012). Hosts employ their miRNAs
in defense against viral infection by targeting viral products
or inhibiting viral replication. Whereas viruses also encode
miRNAs that target speciﬁc host genes and pathways to
prolong the longevity of infected cells or evade the immune
clearance, which may be beneﬁcial for viral infectivity and/or
proliferation (Carl et al., 2013; Kincaid and Sullivan, 2012).
Nevertheless, viral RNAs harbor common miRNA-binding
sites with host RNAs (Jopling et al., 2005; Shimakami et al.,
2012; Song et al., 2010; Klase et al., 2012), indicating that
viral RNAs and mRNAs potentially act as bona ﬁde miRNA
competitors with host RNAs for the same miRNA pool in
infected cells. In addition, a large number of virus-encoded
miRNAs and lncRNAs have been uncovered, which play a
key role in persistent infections, and importantly, a signiﬁcant
portion of viral miRNAs mimic host miRNAs with similar
target sites (Kincaid and Sullivan, 2012). Therefore, we
hypothesize that viral RNAs act as sponges that can
sequester endogenous miRNAs within infected cells and
thus impact the stability and translational efﬁciency of host
mRNAs with shared miRNA response elements (Fig. 1B).
We term the reciprocal regulation between virus and host
transcripts acting in this manner cvhRNAs.
The basis for cvhRNA crosstalk is dependent on base
pairing complementarity and miRNA binding/recognition,
and the ability of viral RNAs (or host mRNAs) to sequester
and degrade miRNAs and the extent of de-repression in host
mRNAs (or viral RNAs) by miRNA down-regulation. Down-
regulation of miRNA by interacting viral or host mRNAs could
be either via sequestration/sponge or destabilization/degra-
dation, or both (Torres et al., 2011), although the exact
mechanisms await further investigation. Thus, the relative
abundance of virus vs. host RNAs, levels of common miR-
NAs, and the number of miRNA response elements may all
contribute to cvhRNA interactions, according to a mathe-
matical mass-action model for ceRNA networks (Ala et al.,
2013). In addition, the intracellular localization of virus/host
mRNAs and miRNAs, the extent of base pairing
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complementarity of the competitive RNAs, as well as the
time-course of viral RNA expression may also impact ceRNA
networks. Given that viruses usually generate highly
redundant transcripts upon infection and that multiple highly
abundant miRNAs interact with viral RNAs or mRNAs (Shi-
makami et al., 2012; Kincaid and Sullivan, 2012), we expect
that reciprocal interactions between viral RNA-miRNA-host
mRNA may orchestrate a permissive molecular environment
that enables the generation of cvhRNA networks under virus
infection.
THE EXPERIMENTAL EVIDENCE FOR CVHRNA
NETWORKS
The existence of cvhRNA cross-talk in viral infections
An early indication that virus-encoded RNAs are involved in
regulating host miRNA abundance came from Cazalla et al.
(2010), who demonstrated that Herpesvirus saimiri (HVS)-
expressed noncoding RNAs have certain miRNA binding
elements and can interact with host miRNAs in virally
transformed T cells. They found that viral ncRNAs down-
regulate mature miR-27 in a binding-dependent manner.
Transient knockdown of one of the ncRNAs, HSUR 1,
resulted in a decreased level of the miR-27 target protein,
FOXO1 (Cazalla et al., 2010). Subsequently, several
impressive experiments have been performed on the role of
coding RNAs and ncRNAs on the degradation and decay of
host miRNAs. Lytic murine cytomegalovirus (MCMV) infec-
tion leads to rapid degradation of cellular miR-27a and miR-
27b via expression of a spliced and highly abundant protein-
coding transcript, m169, which facilitates efﬁcient virus rep-
lication (Marcinowski et al., 2012). Interestingly, MCMV
infection up-regulates expression of genes in mitogen-acti-
vated protein kinases (MAPK) pathway, speciﬁcally p38,
which enhances viral replication (Tang-Feldman et al.,
2013). Up-regulation of p38 may attribute to decreased miR-
27a as p38 is a potential target of miR-27a. Similarly, a viral
intergenic ncRNA element of human cytomegalovirus
(HCMV) mediates the selective down-regulation of mature
miR-17 and miR-20a through sequence-speciﬁc interactions.
Viral RNA-induced miR-17 decay is essential for rapid viral
production, indicating a potential role for the interaction
between the viral ncRNA and cellular miRNAs during viral
pathogenesis (Lee et al., 2013a). Indeed, IL-8 as a target of
miR-17/20a (Yu et al., 2010), signiﬁcantly stimulates HCMV
replication through cytokine-stimulated transcription of viral
late genes and activation of early events in viral replication
(Szabó et al., 1999; Redman et al., 2002).
Hepatitis B virus (HBV), a major hepatotropic DNA virus,
chronically infects ∼350 million people worldwide. Cellular
miRNAs have a striking role in mediating HBV replication
and infection (Hu et al., 2012; Zhang et al.,2013). MiR-122 is
the most abundant liver-speciﬁc miRNA, which reaches
approximately 70% of the total miRNA population in the adult
liver. We observed a signiﬁcant decrease of miR-122 levels
under HBV infection. We further demonstrated that a miR-
122 binding element exists in the 3′-UTR of all four HBV
mRNAs (i.e., the pre-C/C or pre-genomic RNA (pgRNA), pre-
S, S, and X mRNAs), and these viral RNAs act as sponges
to bind and sequester endogenous miR-122, which led to
decreased miR-122. Furthermore, expression of the HBV 3′-
UTR-containing luciferase reporter was sufﬁcient to up-reg-
ulate expression of two cellular genes, cyclin G1 and pitui-
tary tumor-transforming gene 1 (PTTG1) binding factor























Figure 1. Inference of cvhRNA cross-regulation through
miRNA response elements. (A) MiRNAs guide the recognition
of target mRNAs through imperfect matches with their targeting
sites and thus regulate the expression of target mRNAs at the
post-transcriptional level. Each miRNA has multiple (up to tens)
mRNA targets. Conversely, each mRNA may harbor multiple
miRNA targeting sites (Ala et al., 2013). (B) Viral RNAs and
mRNAs harboring miRNA response elements exert their sup-
pression of miRNA as sponges. Host mRNAs may act in a
similar way. Thus, viral RNAs and host mRNAs could compet-
itively sequester the same miRNA pool within infected cells.
Viral RNAs as miRNA sponges can de-repress the miRNA-
mediated inhibition of host mRNAs. Therefore, a cross-regula-
tion may be formed between viral RNAs and host mRNAs that
share common miRNA response elements. Stimulation (↑) or
inhibition (┬) is determined following how miRNAs or RNAs
impact the activities of RNAs or miRNAs.
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element as HBV RNAs (Li et al., 2013; Wang et al., 2012). A
follow-up study revealed that cyclin G1 signiﬁcantly enhan-
ces HBV expression and replication by suppressing p53-
mediated inhibition of HBV enhancers, indicating that the
cross-regulation of HBV RNAs and cyclin G1 expression
possibly contribute to viral persistence. Further, up-regula-
tion of PBF may contribute to HBV infection-related hepa-
tocellular carcinoma (HCC) because PBF interacts with
PTTG1 and increases its transcriptional activity at multiple
oncogenes (Li et al., 2013), as well as promotes cell prolif-
eration, invasion, and HCC tumor growth in mice. Under
HBV infection, the HBV RNA copy number per cell reaches
up to 105 (Li et al., 2013; Wang et al., 2012), and miR-122 is
expressed in hepatocytes at 50,000 copies per cell (Hu
et al., 2012; Filipowicz and Grosshans, 2011). Conceivably,
a positive cross-regulation between HBV RNAs and cyclin
G1 or PBF occurs in the presence of the large amounts of
viral RNAs which efﬁciently sequester miR-122, resulting in
intermediate miR-122 levels in hepatocytes.
Interestingly, we also identiﬁed an IFN-stimulated gene
(ISG), NT5C3, which efﬁciently sequesters miR-122 with its
mRNA 3′-UTR through binding sequence-speciﬁc interac-
tions (Hao et al., 2013). Conceivably, the possible HBV
RNAs-NT5C3 mRNA crosstalk may be a counter mecha-
nism that HBV evolved to antagonize the antiviral activity of
IFN.
In addition to the interaction between HBV RNAs and host
mRNAs that share a common miR-122 response element,
two other groups more recently reported another example of
cvhRNA crosstalk in HBV infection (Liu et al., 2013; Wang
et al., 2013b). They found that the HBx transcript and HBV
mRNAs directly trigger the down-regulation of miR-15a/16
via the miRNA targeting sequences in the viral RNA, and as
a consequence, the target of miR-15a/16 (Bcl-2) is up-reg-
ulated. Up-regulated Bcl-2 then inhibits the downstream
cascade of apoptosis in hepatoma cells. These studies
identify a novel HBx transcript and the HBV mRNAs-miR-
15a/16-Bcl-2 regulatory pathway that is involved in apoptosis
inhibition, which may help facilitate HBV infection and HCC
development.
Together, the above studies provide experimental evi-
dence for the existence of cvhRNA networks during HBV
infection (Fig. 2). CvhRNAs, including HBV RNAs (e.g.,
pgRNA, pre-S, S, and X mRNAs) and host mRNAs (e.g.,
cyclin G1, PBF, NT5C3, and Bcl-2), harbor shared response
elements for certain abundant cellular miRNAs (e.g., miR-
122 and miR-15a/miR-16). When viral RNAs are highly
produced during HBV infection, the repression of host target
genes conferred by these common miRNAs can be diluted
as viral RNAs down-regulate common miRNAs. Up-regula-
tion of host target genes would contribute to enhanced HBV
expression and replication, persistent viral infection, and
HCC development.
HCV (hepatitis C virus), another main hepatotropic posi-
tive-sense RNA virus, causes chronic infection in about 180
million people worldwide. Extensive studies have demon-
strated that miR-122 acts in an unusual manner to stimulate
the replication and expression of HCV by binding to two
closely spaced target sites in the 5′-UTR of the HCV genome
(Jopling et al., 2005; Shimakami et al., 2012; Pang et al.,
2012). In this context, interaction of miR-122 and viral RNA
stabilizes viral RNA and decreases its decay, rather than
induces its degradation as most miRNAs do. Notably, Shan
et al. (2007) showed that inhibition of miR-122 up-regulates
Heme oxygenase-1 (HO-1) which signiﬁcantly inhibits HCV
replication, suggesting that miR-122 promotes HCV repli-
cation partly via down-regulation of HO-1 (Shan et al., 2007).
Considering that HCV RNA also interacts with miR-122, it is
possible that the positive regulatory pathway of HCV RNA-
miR-122-HO-1 may contribute to enhanced HCV replication.
In HBV and HCV infections, robust viral speciﬁc T cell
responses are observed during resolution of acute and self-
limited HBV infections with viral clearance, whereas chronic
infection with viral persistence is characterized by only weak
and impaired T-cell response. T cells are therefore believed
to play a critical role in the control of HBV and HCV repli-
cation and infection (Manigold and Racanelli, 2007; Wang
et al., 2013a). Conceivably, cvhRNA networks may play an
important role in regulation of host immune responses in the
liver microenvironment that induce immune tolerance
towards viruses. Indeed, the above preliminary studies have
shown that the cross-talk and reciprocal interactions
between HBV/HCV RNAs and host mRNAs contribute to
enhanced and persistent viral expression and replication
which inevitably drive T cell tolerance and exhaustion by
long-term intensive viral antigenic stimulation. Moreover, it is
possible that cvhRNA networks in HBV or HCV infection may
directly or indirectly affect expressions of co-inhibitory mol-
ecule programmed death (PD)-1 on Tcells and its ligand PD-
L1 on dendritic cells (DCs), the cytotoxic T lymphocyte
antigen-4 (CTLA-4) and proapoptotic protein Bcl2-interacting
mediator (Bim) on T cells, or activities of Tregs in the liver
microenvironment. Further understanding the regulation of
cvhRNA networks in inﬂuencing the outcome of viral infec-
tions (e.g. viral clearance or persistent infection) will allow
the development of novel strategies for therapeutic regimen
by targeted reversal of tolerising mechanisms.
Prediction of potential cross-regulation between host
and virus by cvhRNA hypothesis
In principle, any viral RNAs sharing common miRNA
response elements with host mRNAs could potentially act as
cvhRNAs and form regulatory networks across the tran-
scriptome. Besides HSV, MCMV and HCMV, we speculate
that other examples of cvhRNA may also exist in viral
infections (Table. 1). For instance, HIV-1 may probably up-
regulate Notch-3 through cvhRNA crosstalk, as both HIV-1
gag-pol and Notch-3 mRNAs share a common miR-150
response sequence (Huang et al., 2007; Ghisi et al., 2011),
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and HIV-1 infection down-regulates miR-150 (Swaminathan
et al., 2009). Notch activation in turn is involved in HIV-
associated nephropathy (Sharma et al., 2010). The cvhRNA
hypothesis also predicts another possible reciprocal
interaction between HIV nef and host PTEN mRNAs that
have a shared miR-29a response sequence. HIV infection
may induce apoptosis of CD4+ T lymphocytes through
upregulating PTEN (Kong et al., 2011; Sun et al., 2012;
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(pg RNA, Pre-S, S, X)
Competitive host mRNAs
(cycin G1, PBF, NT5C3, Bcl-2...)
Enhanced HBV replication (cyclin G1)
Apoptosis inhibition (Bcl-2)
IFN-  antagonsim (NT5C3)
HCC development (PBF, Bcl-2)
Figure 2. Schematic ﬁgure of how cvhRNA networks may mediate viral replication, infection, and the development of HCC
during HBV infection. In hepatocytes, miR-122 effectively suppresses the expression of its target genes (cyclin G1, PBF, and
NT5C3) at the post-transcriptional level by binding to the miRNA response element within the 3′-UTR of target mRNAs. During HBV
infection, high levels of viral RNAs harboring a miR-122 response element in their 3′-UTR competitively sponge and efﬁciently
sequester cellular miR-122, thus blocking the binding of miR-122 to its host target mRNAs. In this manner, viral RNAs de-repress and
rescue the expression of host target mRNAs. Similarly, HBV RNAs positively cross-regulate Bcl-2 expression through shared miR-
15a/16 response elements. The dose effect between competitive HBV RNAs and host mRNAs is shown. In the networks consisting of
four viral RNAs (pgRNA, pre-S, S, and X mRNAs) and four host mRNAs (cyclin G1, PBF, NT5C3, and Bcl-2), elevated expression of
de-repressed host genes contributes to enhanced HBV replication, persistent viral infection, and HCC development.
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Dabrowska et al., 2008). Similarly, inﬂuenza virus WSN
infection induces up-regulation of MMP9 which mRNA
shares a common miR-491-5p binding site with viral PB1
mRNA (Song et al., 2010; Lee et al., 2013b; Yuan et al.,
2013), indicating the potential cross-regulation between viral
mRNA and host mRNA. Furthermore, the notion of cvhRNAs
was recently linked to human papillomaviruses (HPVs)
(Gunasekharan and Laimins, 2013). HPV-31, whose E1 and
E2 open reading frames contain miR-145 binding sequen-
ces, could lead to a dramatic decrease miR-145 level and
increased the expression of a miR-145 target, the cellular
transcription factor KLF-4. HPV-regulated KLF-4 may con-
tribute to the control of viral life cycle during differentiation.
As cvhRNA networks primarily depend on viral mRNA
abundance, different mechanisms responsible for mRNA
production among different virus families above are listed in
Table 2. Among these virus types, ssRNA, dsRNA or dsDNA
genomes serve as the template for mRNA transcription,
some of which even contain a reverse transcription stage in
their replication cycle. This indicates that cvhRNA networks
may exist universally among viruses with different types of
genomes (e.g. ssRNA, dsRNA and dsDNA).
CONCLUSIONS AND OUTLOOK
In conclusion, we speculate that cross-talk between viral
RNAs and host mRNAs via common miRNA response ele-
ments forms complex networks during virus infection, which
may affect viral replication, persistence, and pathogenesis.
This expands the knowledge of how viral RNAs and mRNAs
function in multiple ways, not merely as blueprints for viral
protein synthesis or as PAMPs in innate immunity. Figs. 1
and 2 only show the direct interactions between viral RNAs
and host mRNAs. In general, one miRNA has several or
even multiple RNA/mRNA targets, and conversely, one tar-
get RNA or mRNA likely harbors several miRNA response
elements. Thus, indirect interactions between viral RNAs
and host mRNAs may also play an important role in cvhRNA
networks, which may be further intimately intertwined by
cellular transcription factor networks (Ala et al., 2013). In
addition, variations in miRNA response elements (e.g. the
seed region of pairing) of viral RNA which inevitably affect
base pair complementarity, could thereby inﬂuence the
interactions between viral and host RNAs. To establish
infection, viruses likely evolved to accumulate mutation to
increase the number of shared miRNA response elements
with supportive host factors and decrease the number
shared with inhibitory host factors; this hypothesis deserves
further investigation. Global mRNA and miRNA sequencing,
Gene Ontology analysis of transcriptomic databases and






on viral infection and
pathogenesis
References
HIV-1 gag-pol miR-150 NOTCH3 HIV-associated
nephropathy
Huang et al., 2007; Ghisi et al., 2011;
Swaminathan et al., 2009;
Sharma et al., 2010
Nef miR-29a PTEN Apoptosis in
infected CD4+ T
Lymphocytes
Kong et al., 2011; Sun et al., 2012;
Dabrowska et al., 2008
IAV PB1 miR-491 MMP-9 Severe lung pathology Song et al., 2010; Lee et al., 2013b;
Yuan et al., 2013
HPV E1,E2 miR-145 KLF-4 Control of viral life cycle Gunasekharan and Laimins, 2013
MCMV m169 miR-27a p38 Viral replication and
atherogenesis
Marcinowski et al., 2012;
Tang-Feldman et al., 2013
HCMV UL144-145
RNA
miR-17/20a IL-8 Viral replication Lee et al., 2013a; Yu et al., 2010;
Szabó et al. 1999; Redman et al., 2002
Table 2. Different mechanisms for viral mRNA production
Viruses Genome mRNA production
IAV (−)ssRNA (−)vRNA → mRNA
(−)vRNA → (+)cRNA
→ (−)RNA → mRNA
HCV (+)ssRNA (+)vRNA → mRNA
(+)vRNA → (−)RNA
→ (+)RNA → mRNA
HIV-1 dsRNA dsRNA !RT dsDNA → mRNA
HBV dsDNA DNA → mRNA
DNA → pgRNA
!RT cccDNA → mRNA
HVS dsDNA DNA → mRNA
HPV dsDNA DNA → mRNA
HCMV dsDNA DNA → mRNA
MCMV dsDNA DNA → mRNA
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establishment of proper mathematical models are needed to
provide further dissection of the impact of cvhRNA networks
on virus and host interaction.
A ﬁne-tuned balance between miRNAs and host mRNA
targets (including coding and noncoding transcripts) likely
exists in cells with no viral infection (Ala et al., 2013). Con-
ceivably, viral infection disturbs mRNA homeostasis through
cvhRNA networks, as shown in Fig. 3. Information regarding
the balance between miRNA pools and host mRNA
homeostasis under viral infection is essential to understand
the molecular basis for viral persistence and pathogenesis,
which may facilitate the development of new antiviral
strategies.
An intriguing question arises from the hypothesis of
cvhRNA regulatory networks is why virus evolves to facilitate
rather than avoid miRNA binding which inevitably leads to
repression of viral RNA function. We speculate that virus
may employ either strategy (to usurp cvhRNA networks or to
avoid miRNA targeting) for the establishment of persistent
infection, depending on which strategy plays a major role in
favoring viral infectivity and replication. In particular, some
viruses produce redundant RNA/mRNAs during infections as
miRNAs
response elements
No viral infection Viral infection
Host mRNAs
Host mRNAs homeostasis Disruption of host mRNAs 
homeostasis
Aberrant expression of 
host proteins 




















Figure 3. Potential alteration of host mRNA homeostasis by viral RNAs. Many mammalian viruses produce high levels of
redundant viral RNAs and mRNAs. According to the cvhRNAs hypothesis, under certain conditions for cvhRNA activity in viral
infections, these viral RNAs could modify the balance between cellular miRNAs and host mRNA targets in a miRNA response
sequence dependent and coding independent manner. Viral RNAs directly result in the depression of cellular transcripts with shared
miRNA response elements and the subsequent aberrant expression of host proteins.
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seen in HBV infection (Li et al., 2013; Wang et al., 2012),
which facilitate to form cvhRNA networks.
As emerging studies reveal that cvhRNAs play essential
roles in viral infection and pathogenesis, it will be important
to take into consideration the unique features of direct
communication between viral RNAs and host mRNAs when
studying the interaction between the virus and host in the
long run. We hope that this review of recent advances on
ceRNA and cvhRNA networks will serve to stimulate more
interest and experimental activity and re-deﬁne the concept
of virus-host interactions as more than protein-mediated
regulation.
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